US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist

55.100
+1.230+2.28%

Close Oct 11 16:00 ET

55.100
0.0000.00%

Post 16:01 ET

5.08BMarket Cap-7642P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

33.74%-76.96M

-21.59%-190.73M

-24.80%-474.81M

7.13%-83.9M

-23.63%-117.87M

-50.36%-116.16M

-33.48%-156.87M

-12.33%-380.47M

-66.24%-90.34M

-59.84%-95.35M

Net income from continuing operations

17.66%-131.6M

-4.09%-170.68M

14.25%-606.64M

18.86%-123.19M

34.87%-159.65M

-1.05%-159.83M

-7.65%-163.97M

-55.81%-707.42M

-23.99%-151.83M

-235.77%-245.11M

Depreciation and amortization

65.30%8.86M

68.93%8.85M

42.73%26.01M

65.79%8.22M

53.20%7.19M

19.64%5.36M

28.08%5.24M

37.62%18.22M

40.27%4.96M

45.91%4.69M

Other non cash items

-40,640.74%-11M

-120.96%-2.29M

-101.10%-1.06M

-214.99%-10.14M

-102.17%-1.83M

-102.76%-27K

514.32%10.94M

721.17%96.13M

877.18%8.82M

2,037.11%84.54M

Change In working capital

128.50%16.36M

-46.02%-56.02M

-125.07%-15.1M

-39.11%13.3M

-87.37%2.8M

-74.35%7.16M

-228.21%-38.36M

195.25%60.24M

5.60%21.85M

614.57%22.17M

-Change in receivables

114.31%2.16M

-893.14%-24.91M

-88.75%-22.78M

111.13%1.01M

-204.64%-6.2M

-68.75%-15.08M

-7,700.00%-2.51M

-122.16%-12.07M

-196.25%-9.1M

955.56%5.93M

-Change in inventory

-149.06%-4.13M

-1,516.00%-2.12M

28.56%-6.93M

53.48%-1.96M

-338.31%-3.47M

48.70%-1.66M

110.17%150K

-211.23%-9.7M

-324.75%-4.21M

-1,782.98%-791K

-Change in prepaid assets

----

1,362.62%6.55M

303.50%15.33M

-138.86%-1.26M

----

-105.69%-519K

112.87%3.8M

114.38%3.24M

263.37%7.35M

-Change in payables and accrued expense

115.00%25.33M

-0.15%-35.54M

-97.28%2.38M

-51.10%17.13M

-19.68%8.96M

-79.48%11.78M

-119.54%-35.49M

170.61%87.44M

15.24%35.03M

-17.03%11.16M

-Change in other working capital

----

66.46%-3.1M

48.08%-1.62M

----

83.94%-9.24M

-118.47%-3.12M

87.38%-1.48M

Cash from discontinued investing activities

Operating cash flow

33.74%-76.96M

-21.59%-190.73M

-24.80%-474.81M

7.13%-83.9M

-23.63%-117.87M

-50.36%-116.16M

-33.48%-156.87M

-12.33%-380.47M

-66.24%-90.34M

-59.84%-95.35M

Investing cash flow

Cash flow from continuing investing activities

-39.08%60.56M

-15.16%94.44M

157.60%168M

37.64%-107.02M

139.72%64.3M

25.58%99.42M

397.91%111.3M

-49.28%-291.65M

-348.49%-171.6M

-297.11%-161.86M

Net PPE purchase and sale

85.59%-2.01M

87.17%-3.21M

61.88%-44.27M

94.07%-1.6M

85.81%-3.7M

54.93%-13.94M

22.22%-25.03M

-58.87%-116.12M

-68.06%-26.97M

-26.68%-26.05M

Net intangibles purchase and sale

0.00%-2.5M

---10M

91.67%-2.5M

--0

---2.5M

--0

---30M

--0

Net business purchase and sale

----

--0

----

---75.03M

--366K

----

Net investment purchase and sale

-43.99%65.11M

-21.80%109.71M

415.55%219.82M

27.18%-105.15M

213.57%68.42M

5.42%116.25M

467.93%140.29M

42.59%-69.66M

-268.76%-144.39M

-205.63%-60.25M

Net other investing changes

89.70%-41K

47.73%-2.07M

-498.10%-5.05M

55.13%-271K

-141.81%-428K

-117.49%-398K

-3,392.50%-3.95M

10.40%-844K

-32.75%-604K

---177K

Cash from discontinued investing activities

Investing cash flow

-39.08%60.56M

-15.16%94.44M

157.60%168M

37.64%-107.02M

139.72%64.3M

25.58%99.42M

397.91%111.3M

-49.28%-291.65M

-348.49%-171.6M

-297.11%-161.86M

Financing cash flow

Cash flow from continuing financing activities

1,065.78%384.94M

91.97%-58K

-22.56%388.14M

17,466.95%330.61M

-94.87%25.23M

465.70%33.02M

-144.79%-722K

322.77%501.21M

-97.80%1.88M

6,414.93%491.88M

Net common stock issuance

----

--379.76M

--326.46M

--24.79M

----

--0

Proceeds from stock option exercised by employees

-10.86%4.07M

92.27%-58K

-22.18%8.42M

107.60%4.15M

-58.85%442K

-23.63%4.57M

-142.74%-750K

-73.04%10.81M

-71.10%2M

-86.00%1.07M

Net other financing activities

----

-100.01%-28K

--0

61.64%-56K

119.58%28K

99,773.78%490.4M

16.20%-119K

395,908.87%490.8M

Cash from discontinued financing activities

Financing cash flow

1,065.78%384.94M

91.97%-58K

-22.56%388.14M

17,466.95%330.61M

-94.87%25.23M

465.70%33.02M

-144.79%-722K

322.77%501.21M

-97.80%1.88M

6,414.93%491.88M

Net cash flow

Beginning cash position

33.70%122.37M

59.45%219.4M

-55.55%137.6M

-80.17%78.61M

-33.83%107.67M

-41.41%91.53M

-55.55%137.6M

-57.37%309.59M

89.13%396.31M

-46.28%162.72M

Current changes in cash

2,164.18%368.54M

-108.17%-96.35M

147.59%81.34M

153.71%139.69M

-112.08%-28.35M

110.08%16.28M

69.80%-46.29M

58.87%-170.91M

-358.92%-260.06M

352.72%234.67M

Effect of exchange rate changes

-376.47%-648K

-421.80%-679K

142.98%462K

-18.42%1.1M

33.77%-716K

89.01%-136K

295.37%211K

9.97%-1.08M

444.90%1.35M

-125.68%-1.08M

End cash Position

355.35%490.26M

33.70%122.37M

59.45%219.4M

-80.17%78.61M

-33.83%107.67M

-41.41%91.53M

-55.55%137.6M

89.13%396.31M

Free cash flow

38.56%-81.47M

-12.11%-203.94M

0.95%-521.57M

27.11%-85.5M

-0.15%-121.57M

-22.57%-132.6M

-1.22%-181.9M

-27.88%-526.59M

-66.66%-117.31M

-51.34%-121.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	33.74%-76.96M	-21.59%-190.73M	-24.80%-474.81M	7.13%-83.9M	-23.63%-117.87M	-50.36%-116.16M	-33.48%-156.87M	-12.33%-380.47M	-66.24%-90.34M	-59.84%-95.35M
Net income from continuing operations	17.66%-131.6M	-4.09%-170.68M	14.25%-606.64M	18.86%-123.19M	34.87%-159.65M	-1.05%-159.83M	-7.65%-163.97M	-55.81%-707.42M	-23.99%-151.83M	-235.77%-245.11M
Depreciation and amortization	65.30%8.86M	68.93%8.85M	42.73%26.01M	65.79%8.22M	53.20%7.19M	19.64%5.36M	28.08%5.24M	37.62%18.22M	40.27%4.96M	45.91%4.69M
Other non cash items	-40,640.74%-11M	-120.96%-2.29M	-101.10%-1.06M	-214.99%-10.14M	-102.17%-1.83M	-102.76%-27K	514.32%10.94M	721.17%96.13M	877.18%8.82M	2,037.11%84.54M
Change In working capital	128.50%16.36M	-46.02%-56.02M	-125.07%-15.1M	-39.11%13.3M	-87.37%2.8M	-74.35%7.16M	-228.21%-38.36M	195.25%60.24M	5.60%21.85M	614.57%22.17M
-Change in receivables	114.31%2.16M	-893.14%-24.91M	-88.75%-22.78M	111.13%1.01M	-204.64%-6.2M	-68.75%-15.08M	-7,700.00%-2.51M	-122.16%-12.07M	-196.25%-9.1M	955.56%5.93M
-Change in inventory	-149.06%-4.13M	-1,516.00%-2.12M	28.56%-6.93M	53.48%-1.96M	-338.31%-3.47M	48.70%-1.66M	110.17%150K	-211.23%-9.7M	-324.75%-4.21M	-1,782.98%-791K
-Change in prepaid assets	----	1,362.62%6.55M	303.50%15.33M	-138.86%-1.26M	----	----	-105.69%-519K	112.87%3.8M	114.38%3.24M	263.37%7.35M
-Change in payables and accrued expense	115.00%25.33M	-0.15%-35.54M	-97.28%2.38M	-51.10%17.13M	-19.68%8.96M	-79.48%11.78M	-119.54%-35.49M	170.61%87.44M	15.24%35.03M	-17.03%11.16M
-Change in other working capital	----	----	66.46%-3.1M	48.08%-1.62M	----	----	----	83.94%-9.24M	-118.47%-3.12M	87.38%-1.48M
Cash from discontinued investing activities
Operating cash flow	33.74%-76.96M	-21.59%-190.73M	-24.80%-474.81M	7.13%-83.9M	-23.63%-117.87M	-50.36%-116.16M	-33.48%-156.87M	-12.33%-380.47M	-66.24%-90.34M	-59.84%-95.35M
Investing cash flow
Cash flow from continuing investing activities	-39.08%60.56M	-15.16%94.44M	157.60%168M	37.64%-107.02M	139.72%64.3M	25.58%99.42M	397.91%111.3M	-49.28%-291.65M	-348.49%-171.6M	-297.11%-161.86M
Net PPE purchase and sale	85.59%-2.01M	87.17%-3.21M	61.88%-44.27M	94.07%-1.6M	85.81%-3.7M	54.93%-13.94M	22.22%-25.03M	-58.87%-116.12M	-68.06%-26.97M	-26.68%-26.05M
Net intangibles purchase and sale	0.00%-2.5M	---10M	91.67%-2.5M	--0	--0	---2.5M	--0	---30M	--0	--0
Net business purchase and sale	----	----	--0	--0	----	----	----	---75.03M	--366K	----
Net investment purchase and sale	-43.99%65.11M	-21.80%109.71M	415.55%219.82M	27.18%-105.15M	213.57%68.42M	5.42%116.25M	467.93%140.29M	42.59%-69.66M	-268.76%-144.39M	-205.63%-60.25M
Net other investing changes	89.70%-41K	47.73%-2.07M	-498.10%-5.05M	55.13%-271K	-141.81%-428K	-117.49%-398K	-3,392.50%-3.95M	10.40%-844K	-32.75%-604K	---177K
Cash from discontinued investing activities
Investing cash flow	-39.08%60.56M	-15.16%94.44M	157.60%168M	37.64%-107.02M	139.72%64.3M	25.58%99.42M	397.91%111.3M	-49.28%-291.65M	-348.49%-171.6M	-297.11%-161.86M
Financing cash flow
Cash flow from continuing financing activities	1,065.78%384.94M	91.97%-58K	-22.56%388.14M	17,466.95%330.61M	-94.87%25.23M	465.70%33.02M	-144.79%-722K	322.77%501.21M	-97.80%1.88M	6,414.93%491.88M
Net common stock issuance	----	----	--379.76M	--326.46M	--24.79M	----	----	--0	--0	--0
Proceeds from stock option exercised by employees	-10.86%4.07M	92.27%-58K	-22.18%8.42M	107.60%4.15M	-58.85%442K	-23.63%4.57M	-142.74%-750K	-73.04%10.81M	-71.10%2M	-86.00%1.07M
Net other financing activities	----	----	-100.01%-28K	--0	--0	61.64%-56K	119.58%28K	99,773.78%490.4M	16.20%-119K	395,908.87%490.8M
Cash from discontinued financing activities
Financing cash flow	1,065.78%384.94M	91.97%-58K	-22.56%388.14M	17,466.95%330.61M	-94.87%25.23M	465.70%33.02M	-144.79%-722K	322.77%501.21M	-97.80%1.88M	6,414.93%491.88M
Net cash flow
Beginning cash position	33.70%122.37M	59.45%219.4M	-55.55%137.6M	-80.17%78.61M	-33.83%107.67M	-41.41%91.53M	-55.55%137.6M	-57.37%309.59M	89.13%396.31M	-46.28%162.72M
Current changes in cash	2,164.18%368.54M	-108.17%-96.35M	147.59%81.34M	153.71%139.69M	-112.08%-28.35M	110.08%16.28M	69.80%-46.29M	58.87%-170.91M	-358.92%-260.06M	352.72%234.67M
Effect of exchange rate changes	-376.47%-648K	-421.80%-679K	142.98%462K	-18.42%1.1M	33.77%-716K	89.01%-136K	295.37%211K	9.97%-1.08M	444.90%1.35M	-125.68%-1.08M
End cash Position	355.35%490.26M	33.70%122.37M	59.45%219.4M	59.45%219.4M	-80.17%78.61M	-33.83%107.67M	-41.41%91.53M	-55.55%137.6M	-55.55%137.6M	89.13%396.31M
Free cash flow	38.56%-81.47M	-12.11%-203.94M	0.95%-521.57M	27.11%-85.5M	-0.15%-121.57M	-22.57%-132.6M	-1.22%-181.9M	-27.88%-526.59M	-66.66%-117.31M	-51.34%-121.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data